Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4731 Reports
🤖 AI Analyzed
Recent
📄 Page 95 of 395
Rein Therapeutics, Inc.
10-K March 26, 2026

Key Highlights

  • Strategic pivot to LTI-03 peptide platform for pulmonary fibrosis
  • Successful $15 million capital raise to extend operations into Q2 2026
  • Corporate rebranding from Aileron to Rein Therapeutics to signal new focus
Read Analysis
🤖 AI Generated
GALAPAGOS NV
20-F March 26, 2026

Key Highlights

  • Significant cash position of €3.2 billion provides a runway through 2027.
  • Strategic pivot toward immunology and oncology to streamline operations.
  • Aggressive cost-cutting measures targeting €150 million in annual savings.
Read Analysis
🤖 AI Generated
BTCS Inc.
10-K March 26, 2026

Key Highlights

  • Achieved 305% annual revenue growth, reaching $16.5 million.
  • Builder+ service emerged as a dominant revenue driver, contributing 80% of total...
  • Successfully scaled operations to over 200 validator nodes.
Read Analysis
🤖 AI Generated
COGNITION THERAPEUTICS INC
10-K March 26, 2026

Key Highlights

  • Lead drug candidate zervimesine (CT1812) is currently in Phase 2 clinical trials...
  • Secured a significant $30 million non-dilutive grant from the National Institute...
  • Focused on a novel therapeutic approach targeting the sigma-2 receptor complex t...
Read Analysis
🤖 AI Generated
Orgenesis Inc.
10-K March 26, 2026

Key Highlights

  • Innovative 'Point-of-Care' platform decentralizes cell and gene therapy manufact...
  • Strategic shift toward cost-cutting and asset divestiture to stabilize operation...
  • Global footprint spanning the U.S., Israel, and Europe via research partnerships...
Read Analysis
🤖 AI Generated

Key Highlights

  • Systematic 'all-weather' trading strategy across 100+ global markets.
  • Proven ability to generate returns in both rising and falling markets.
  • Managed by Graham Capital Management, an industry veteran overseeing $20 billion...
Read Analysis
🤖 AI Generated

Key Highlights

  • Diversified hedge strategy designed to move independently of the S&P 500.
  • Dual-strategy approach combining human discretionary analysis with systematic co...
  • Managed by Graham Capital Management, a firm overseeing over $20 billion in asse...
Read Analysis
🤖 AI Generated
Arcadia Biosciences, Inc.
10-K March 26, 2026

Key Highlights

  • Divested GoodWheat business for $7.7 million to streamline operations.
  • Transitioned to a pure-play consumer wellness company focused on Zola coconut wa...
  • Terminated merger agreement with Roosevelt Resources, maintaining independence.
Read Analysis
🤖 AI Generated

Key Highlights

  • Lead program BRTX-100 received FDA 'Fast Track' status for chronic lower back di...
  • Positive clinical trial data: 74% of patients showed improved function and 72% r...
  • Expanded patent portfolio for ThermoStem in the U.S., Europe, and Israel.
Read Analysis
🤖 AI Generated
CV Sciences, Inc.
10-K March 26, 2026

Key Highlights

  • Successful turnaround strategy reducing net losses from $2.4M to $0.9M.
  • Improved operational efficiency with gross profit margins rising to 49%.
  • Strong innovation pipeline with 39% of revenue derived from new products.
Read Analysis
🤖 AI Generated
AmpliTech Group, Inc.
10-K March 26, 2026

Key Highlights

  • Strategic transition from service provider to original equipment manufacturer (O...
  • Acquisition of Titan APA intellectual property to own the 5G technology stack.
  • Targeting high-growth sectors including 5G, quantum computing, and aerospace.
Read Analysis
🤖 AI Generated

Key Highlights

  • Successful pivot from volatile crypto mining to stable financial advisory servic...
  • Operates as a licensed broker-dealer via Chaince Securities with SEC and FINRA r...
  • Focuses on high-margin capital market services including IPOs and corporate rest...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage